Veterinary Pharmaceuticals Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Global Veterinary Pharmaceuticals Market By Product Type (Antimicrobials, Ectoparasiticides, Endoparacitides, Endectoparaciticides, Anti-inflammatory Drugs, Anti-Obesity Drugs, Behavioral Products, Biologic Drugs and Others), By Animal Type (Farm Animals (Livestock, Poultry, Swine, and Equine) Companion Animals (Feline, Canine, and Avian), and Aquaculture), By Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Veterinary Pharmacies, Veterinary Hospitals, Veterinary Clinics, and E-Commerce), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Veterinary Pharmaceuticals Market size is valued at USD 31.36 billion in 2021 and is expected to reach USD 55.52 billion by 2028, at a CAGR of 7.74% during the forecast period 2022-2028. Veterinary drugs and allied services are used to treat and/or improve the performance and health of animals. These medications are used to treat injuries, illnesses, and diseases in animals. Veterinary medicine comprises vaccines, veterinary medicines such antibacterial drugs, and diagnostic kits for curing pathogens in animals. Furthermore, the medicine is mostly used for animal health care, surgery, and prevention. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global Veterinary Pharmaceuticals market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Veterinary Pharmaceuticals Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Veterinary Pharmaceuticals Market

MARKET SUMMARY
-
7.74%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 7.74%
  • Largest Market– Asia Pacific
  • Fastest Growing Market– Europe

Veterinary Pharmaceuticals Market

  • The global Veterinary Pharmaceuticals Market report gives comprehensive outlook on Veterinary Pharmaceuticals Market across the globe with special emphasis on key regions such as  North America, Asia Pacific, Europe, Latin America, and Middle East and Africa.
  • The report on global Veterinary Pharmaceuticals Market gives historical, current, and future market sizes (US$ Mn) on the basis of type, end-user and Region.
key players
  • Bayer AG (Germany)
  • Boehringer Ingelheim GmbH (Germany)
  • Ceva Santé Animale (France)
  • Eli Lilly and Company (U.S)
  • Heska Co. (U.S)
Veterinary Pharmaceuticals Market

DRIVERS AND RESTRAINTS

The medicinal feed additives segment is also expected to witness a significant growth rate over the forecast period owing to their increasing usage in maintaining animal health. Furthermore, the rising global population is increasing the demand for meat as well as dairy, which also drives the growth of the medicinal feed additives segment.


North-America got significant share

Veterinary Pharmaceuticals Market

Currently, North America market leads the global market and projected to remain same over the forecast period owing to rising consumption of protein food. Europe veterinary pharmaceuticals market holds a significant share in global market and projected to grow at significant CAGR.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Findings of the Report

  • Veterinary pharmaceuticals market expanding at 7.74% CAGR over 2022 to 2028 to reach market value of US$ 55.52 Bn by 2028
  • Based on product type antimicrobials accounted for larger market revenue share in 2021 and projected gain larger market revenue share over the forecast period
  • Veterinary pharmacies distribution channel is the prime source for veterinary pharmaceuticals across the globe and expected to remain attractive over the forecast period
  • Players focusing on launching products to retain market position in global market

Key

Features of the Report

Veterinary Pharmaceuticals Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

1. Research Methodology
1.1. Secondary and Primary research
1.1.1. Secondary Sources
1.1.2. Primary Sources
1.2. Market Revenue Estimation Methodology
1.3. Key Assumptions
1.4. Acronyms
2. Scope of Study
2.1. Market Definition
2.2. Objective of the Research
2.3. Regions covered in the study
3. Executive summary
4. Global Veterinary Pharmaceuticals Market Dynamic Factors
4.1. Drivers
4.1.1. Economic Drivers
4.1.2. Demand Side Drivers
4.1.3. Supply Side Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends
5. Unique Features of the Report
5.1. Competition analysis
5.1.1. Dash board of top players
5.1.2. Financial Analysis
5.1.3. Product & Services
5.1.4. Key Developments
5.1.5. Major Strategies
5.1.6. SWOT Analysis
5.2. Technological advancements in veterinary pharmaceuticals market
5.3. Recent investments in the industry
5.4. Regulatory landscape
5.4.1. U.S.
5.4.2. Europe
5.5. PESTLE analysis
5.6. Porter’s analysis
6. Global Veterinary Pharmaceuticals Market , By Product, 2015 – 2019 and Forecast, 2020 – 2026
6.1. Product Type
6.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.3. Antimicrobials
6.1.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.4. Ectoparasiticides
6.1.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.5. Endoparacitides
6.1.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.6. Endectoparaciticides
6.1.6.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.7. Anti-inflammatory Drugs
6.1.7.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.8. Anti-Obesity Drugs
6.1.8.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.9. Behavioral Products
6.1.9.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.10. Biologic Drugs
6.1.10.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.1.11. Others
6.1.11.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1.11.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7. Global Veterinary Pharmaceuticals Market Forecast, By Animal, 2015 – 2019 and Forecast, 2020 – 2026
7.1. Farm Animals
7.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.1.3. Livestock
7.1.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.1.4. Poultry
7.1.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.1.5. Swine
7.1.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.1.6. Equine
7.1.6.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.1.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2. Companion Animal
7.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2.3. Feline
7.2.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2.4. Canine
7.2.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2.5. Avian
7.2.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.2.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.3. Aqua Culture
7.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

8. 8. Global Veterinary Pharmaceuticals Market Forecast, By Route of administration, 2015 – 2019 and Forecast, 2020 – 2026
8.1. Oral
8.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.2. Parenteral
8.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.3. Topical
8.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.4. Others
8.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9. Global Veterinary Pharmaceuticals Market Forecast, By Distribution Channel, 2015 – 2019 and Forecast, 2020 – 2026
9.1. Veterinary Pharmacies
9.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.2. Veterinary Clinics
9.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.3. Veterinary Hospitals
9.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9.4. Others
9.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
10. Veterinary Pharmaceuticals Market Forecast, By Region Analysis, 2015 – 2019 and Forecast, 2020 – 2026
10.1. North America Veterinary Pharmaceuticals Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
10.1.1. Product Analysis 2015 – 2019 and Forecast, 2020 – 2026 by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.1.1. Product type
10.1.1.1.1. Antimicrobials
10.1.1.1.2. Ectoparasiticides
10.1.1.1.3. Endoparacitides
10.1.1.1.4. Endectoparaciticides
10.1.1.1.5. Anti-inflammatory Drugs
10.1.1.1.6. Anti-Obesity Drugs
10.1.1.1.7. Behavioral Products
10.1.1.1.8. Biologic Drugs
10.1.1.1.9. Others
10.1.2. Animal Type Analysis 2015 – 2019 and Forecast, 2020 – 2026 by Revenue (USD Mn) and Y-o-Y Growth (%)
10.1.2.1. Farm Animal
10.1.2.1.1. Livestock
10.1.2.1.2. Poultry
10.1.2.1.3. Swine
10.1.2.1.4. Equine
10.1.2.2. Companion Animal
10.1.2.2.1. Feline
10.1.2.2.2. Canine
10.1.2.2.3. Avian


Report

Company Profile

  • Bayer AG (Germany)
  • Boehringer Ingelheim GmbH (Germany)
  • Ceva Santé Animale (France)
  • Eli Lilly and Company (U.S)
  • Heska Co. (U.S)
  • Hester biosciences (India)
  • Merck & Co., Inc. (U.S)
  • Perrigo Company plc. (Ireland)
  • Vétoquinol S.A. (France)
  • Virbac S.A. (France)
  • Zoetis Inc. (U.S)

Description

Veterinary Pharmaceuticals Market size is valued at USD 31.36 billion in 2021 and is expected to reach USD 55.52 billion by 2028, at a CAGR of 7.74% during the forecast period 2022-2028. Veterinary drugs and allied services are used to treat and/or improve the performance and health of animals. These medications are used to treat injuries, illnesses, and diseases in animals. Veterinary medicine comprises vaccines, veterinary medicines such antibacterial drugs, and diagnostic kits for curing pathogens in animals. Furthermore, the medicine is mostly used for animal health care, surgery, and prevention. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global Veterinary Pharmaceuticals market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Veterinary Pharmaceuticals Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX